| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/18/2009 | CN101370828A Anti-inflammatory dab |
| 02/18/2009 | CN101370827A Pharmaceutical compositions with resistance to soluble CEA |
| 02/18/2009 | CN101370826A Secreted frizzled related protein-4 (SFRP-4) protein binding agents |
| 02/18/2009 | CN101370526A Recombinant monovalent antibodies and methods for production thereof |
| 02/18/2009 | CN101368183A Preparation of tomato EIL1 recombinant protein and uses thereof |
| 02/18/2009 | CN101368173A Antihuman CD44 monoclone antibody hybridoma cell line, monoclone antibody, engineering antibody, carrier, reagent kit and uses thereof |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101367876A Monoclonal antiidiotypic antibody NP30 single-specificity double-chain antibody of Japanese blood fluke, preparation method and uses thereof |
| 02/18/2009 | CN101367875A N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 02/18/2009 | CN101367874A Anti-amyloid antibodies, compositions, methods and uses |
| 02/18/2009 | CN100462432C Hybridoma cell strain, and anti-human heparin enzyme monoclonal anti-body produced by the same |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491804 DNA dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 02/17/2009 | US7491803 Atopic dermatitis, airway inflammation, airway hyperresponsiveness, or asthma; cytokine biosynthesis inhibition; diagnostic kits |
| 02/17/2009 | US7491802 Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491703 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 02/17/2009 | US7491700 Contacting a cell with a peptide compound capable of inducing a conformational change in Bcl-2; converting the Bcl-2 into a pro-apoptotic form |
| 02/17/2009 | US7491699 Peptide nanostructures and methods of generating and using the same |
| 02/17/2009 | US7491530 Hybrid cell for producing immunoglobulins for diagnosis and treatment of cell proliferative, infectious autoimmune and tumor disorders |
| 02/17/2009 | US7491529 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy |
| 02/17/2009 | US7491512 recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein; from E. coli, or yeast cell; vectors, host cells; produce immunostimulants, immunosuppressants, agonists, antagonists, biodrugs |
| 02/17/2009 | US7491490 For inhibition of viral entry into cells |
| 02/17/2009 | US7491405 Antigenic protein originating in Malassezia |
| 02/17/2009 | US7491398 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/17/2009 | US7491393 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | US7491391 Anti-IL-23 antibodies, compositions, methods and uses |
| 02/17/2009 | US7491389 Bone marrow; controlling cell differentiation |
| 02/17/2009 | CA2637346A1 Muscle lamin a/c interacting protein, gene encoding same, and uses therefor |
| 02/17/2009 | CA2473101C Immunoassays |
| 02/17/2009 | CA2325983C Drug delivery of proteins from polymeric blends |
| 02/17/2009 | CA2318030C Acpl dna and polypeptides |
| 02/17/2009 | CA2316411C Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 02/17/2009 | CA2180957C Cloning and recombinant production of crf receptor(s) |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/15/2009 | CA2628900A1 Monoclonal antibodies against .beta.3 integrins |
| 02/12/2009 | WO2009020964A2 Anti-neublastin antibodies and uses thereof |
| 02/12/2009 | WO2009020933A2 Therapeutic use of anti-tweak receptor antibodies |
| 02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
| 02/12/2009 | WO2009020632A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020028A1 Determination and suppression of expression level of g protein-coupled receptor kinase 4 gene in breast cancer cell |
| 02/12/2009 | WO2009019493A1 Antibodies binding human prostate epithelial cells |
| 02/12/2009 | WO2009019465A1 Insulin-like growth factor fusion proteins |
| 02/12/2009 | WO2009019456A1 Interferon fusion proteins |
| 02/12/2009 | WO2009019427A1 Leptin fusion proteins |
| 02/12/2009 | WO2009019312A2 Anti cd37 antibodies |
| 02/12/2009 | WO2009018625A1 Treatment of prion protein related diseases |
| 02/12/2009 | WO2008145338A3 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 02/12/2009 | WO2008145137A3 Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering |
| 02/12/2009 | WO2008143702A3 Anti-mrp3 antibodies and methods of use |
| 02/12/2009 | WO2008134724A3 Methods for administering anti-il-5 antibodies |
| 02/12/2009 | WO2008113770A3 Anti-androgen peptides and uses thereof in cancer therapy |
| 02/12/2009 | WO2008103845A3 Monoclonal antibodies that neutralize anthrax toxins |
| 02/12/2009 | WO2008008709A4 Method of selective protein enrichment and associated applications |
| 02/12/2009 | WO2007014743A8 Cd33-specific single-chain immunotoxin and method of use |
| 02/12/2009 | US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042792 18 human secreted proteins |
| 02/12/2009 | US20090042785 Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (Ctla-4) |
| 02/12/2009 | US20090042780 Modified TGF-Beta Superfamily Polypeptides and Related Methods |
| 02/12/2009 | US20090042768 Purine derivatives and their use for treatment of autoimmune diseases |
| 02/12/2009 | US20090042740 Novel Method for Cloning Variable Domain Sequences of Immunological Gene Repertoire |
| 02/12/2009 | US20090042738 Tyrosylprotein sulfotransferases and methods of use thereof |
| 02/12/2009 | US20090042292 B7-DC Variants |
| 02/12/2009 | US20090042285 Antibodies at T cell receptor mimics, methods of production and uses thereof |
| 02/12/2009 | US20090042284 Method for labeling/separation of cells and agent for labeling/separation of cells |
| 02/12/2009 | US20090042270 Activatable recombinant neurotoxins |
| 02/12/2009 | US20090042233 Novel protein member of the ras/mapk pathway, antibodies thereof and methods and kits of using same |
| 02/12/2009 | US20090042226 Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer) |
| 02/12/2009 | US20090042222 Peptides for Detection of Antibody to Anaplasma phagocytophilum |
| 02/12/2009 | US20090042220 Kit comprising epitope specific immunoglobulin for use in diagnosis/prognosis of bone disorders; Antiarthritic agents; screenning for osteoarthritis |
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/12/2009 | US20090042201 Biomarkers for multiple sclerosis and methods of use thereof |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
| 02/12/2009 | US20090041797 Modified toxins |
| 02/12/2009 | US20090041796 Surface protein of leptospira |
| 02/12/2009 | US20090041790 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 02/12/2009 | US20090041789 Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen |
| 02/12/2009 | US20090041788 Apo-2L receptor agonist and CPT-11 synergism |
| 02/12/2009 | US20090041787 Chemokine receptor antagonists as therapeutic agents |
| 02/12/2009 | US20090041785 Use of anti-integrin antibodies for reducing scar tissue formation |
| 02/12/2009 | US20090041784 Compositions and methods relating to glucagon receptor antibodies |
| 02/12/2009 | US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
| 02/12/2009 | US20090041781 A substantially pure IgE anti-Parvovirus B19 antibody useful for diagnosis and prognosis of parvovirus infected patients by detecting the presence of immunoglobulin E anti-Parvovirus B19 antibodies; antibody-based compositions; viricides |
| 02/12/2009 | US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening |
| 02/12/2009 | US20090041776 Production of cancer-specific antibodies in plants |
| 02/12/2009 | US20090041775 Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
| 02/12/2009 | US20090041772 Soluble Forms of Hendra and Nipah Virus G Glycoprotein |
| 02/12/2009 | US20090041771 Immunological methods and compositions for the treatment of Alzheimer's disease |